Emerald Acquisition’s CytomX Therapeutics CTMX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q3
$342K Sell
21,842
-21,842
-50% -$342K ﹤0.01% 2571
2016
Q2
$446K Buy
+43,684
New +$446K ﹤0.01% 2517